Search company, investor...


Series B | Alive

About 1747

1747, with headquarters in San Francisco, is a leader in direct-to-participant clinical trials conducted directly with participants by means of the Internet. 1747 founders have decades of experience in teaching research methodology and conducting standard clinical trials for industry and the National Institute for Health. 1747's first trial, KALM, efficiently compared two nutraceuticals, Kava and Valerian, versus placebo for anxiety and insomnia.

Headquarters Location

2565 Third St Unit 320

San Francisco, California, 94107,

United States




1747 Frequently Asked Questions (FAQ)

  • Where is 1747's headquarters?

    1747's headquarters is located at 2565 Third St, San Francisco.

  • What is 1747's latest funding round?

    1747's latest funding round is Series B.

  • Who are the investors of 1747?

    Investors of 1747 include Lilly Ventures and Sears Capital Management.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.